EpiMab Biotherapeutics Wins Fortune China Innovation of the Year
December 8, 2017

The Fortune China Innovation Award, co-established by Fortune magazine and the municipal government of Guangzhou, is aimed at encouraging startups that excel in scientific and technological innovation in China. Since its announcement in May, the award attracted over 100 entrants, 15 of which made it to the final round.

Five finalists came out as winners in five categories: BZN (保準牛), for e-commerce and fintech; EpimAb (上海岸邁生物科技), a Shanghai-based bio-pharm R&D firm, for healthcare tech; Saphlux, a company commercializing semi-polar gallium nitride, for mobility and green tech; Chaitin (長亭科技), a leading artificial intelligence (AI)-based, semantic analysis powered firewall web application, for AI and robotics; and Yixue Education (乂學教育), developer of the first self-adaptive learning engine for online education in China, for new media, entertainment and education. Each of them was awarded a Trumpchi car by the Guangzhou Automobile Group

 

Copyright ? 2011 Decheng Capital LLC. All Rights Reserved.
浙江20选5预测推荐 腾讯分分彩计划专业版 三升体育app平台 微乐宁夏麻将苹果版下载 3d杀组选复式投注技巧 河内5分彩走势图AC值 重庆快乐10分一定牛1000期 江苏11选5玩法技巧集锦 三分彩实时开奖 足球比分推荐分析网 狗狗币官网价格 无押金2毛5毛微信麻将群有没有 双色球129期开奖号码预测 福彩湖北30选5开奖结果查询结果 每日签到领彩金的彩票平台 重庆时时彩后二技巧—点击进入 排列五走势图大赢家